Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/OLEMA-PHARMACEUTICALS-INC-115395186/nieuws/Olema-Pharmaceuticals-Inc-nomineert-OP-3136-een-oraal-biobeschikbare-KAT6-remmer-als-ontwikkelin-45694731/?utm_source=whatsapp&utm_medium=social&utm_campaign=share